Canadian Securities ExchangeThe Daily Bell

Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc. (CSE:DRUG) is listed on the Canadian Securities Exchange in the Life Sciences sector, since February 8, 2021. The CSE has covered it in 2 stories and one CSE TV video since 2021.

CSE:DRUGCompany profile on thecse.com

On CSE TV

Stories (2)

Dec 15, 2021CSE Issuer Stories

Bright Minds Biosciences: A vision for “next generation” psychedelic medicines to treat neurological conditions

With the COVID-19 pandemic upending life in every corner of the world and putting unwelcome pressure on people vulnerable to depression, suicide and addiction, there has never been a better time to consider new treatments for mental health challenges. One field gaining particularly rapid traction is psychedelics. Of course, substances such as LSD and magic…

Nov 25, 2021CSE Issuer Stories

Canadian Securities Exchange Magazine: The Psychedelics Issue – Now Live!

Welcome to the latest issue of the Canadian Securities Exchange Magazine, your source for in-depth stories of entrepreneurs from a wealth of different industries. Psychedelics has emerged as a rapidly-evolving industry in the last few years. In this issue of Canadian Securities Exchange Magazine, we’re thrilled to share stories of visionary entrepreneurs in this sector.…